Treatmentexperimental

Thymosin Beta-4 / TB-500 Therapy

A peptide (and its research fragment TB-500) marketed for tissue repair, tendon/muscle recovery, wound healing and inflammation.

A peptide (and its research fragment TB-500) marketed for tissue repair, tendon/muscle recovery, wound healing and inflammation. Sold as an injectable recovery protocol, often paired with BPC-157.

Evidence

experimental

Recovery and longevity claims rest on preclinical/animal data and anecdote with no adequate human trials, leaving the marketed benefits unproven.

Regulatory notes

European Union
No EMA/AEMPS marketing authorisation; not a legal approved human medicine.
United States
Not FDA-approved for human use; TB-500 was proposed NOT to be added to the 503A Bulks List and referred to PCAC review; also banned in sport (WADA).
United Arab Emirates
Not DHA/DoH-registered; unapproved for prescription or import as a licensed medicine.
United Kingdom
Not MHRA-licensed; prohibited in sport and not available as an approved wellness product.

General information, not medical or legal advice. See our disclaimer.

Also known as

TB-500, TB500, thymosin beta 4, TB-4, Tβ4, thymosin beta-4 fragment

Where to find it

40 clinics in the directory offer thymosin beta-4 / tb-500 therapy. Prices shown are the cheapest for this treatment where published; always confirm with the venue.

Back to glossary